Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mouret

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|July 10, 2021
Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancerA Petitcollin, N Azzopardi, J Y Pierga, et al.
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
BMC Cancer|November 27, 2010
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worseEmilie Thivat, Sophie Thérondel, Olivier Lapirot, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancersC Abrial, M A Mouret-Reynier, S Amat, et al.
Cancer Investigation|October 21, 2011
Prognostic value of initial tumor parameters after metastatic relapseE Planchat, X Durando, C Abrial, et al.
Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.
Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.
Breast (Edinburgh, Scotland)|August 20, 2011
Late lines of treatment benefit survival in metastatic breast cancer in current practice?E Planchat, C Abrial, E Thivat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution studyE Monrigal, J Dauplat, P Gimbergues, et al.
Annals of Surgical Oncology|March 4, 2008
Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentationP Gimbergues, C Abrial, X Durando, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|July 10, 2021
Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancerA Petitcollin, N Azzopardi, J Y Pierga, et al.
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
BMC Cancer|November 27, 2010
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worseEmilie Thivat, Sophie Thérondel, Olivier Lapirot, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancersC Abrial, M A Mouret-Reynier, S Amat, et al.
Cancer Investigation|October 21, 2011
Prognostic value of initial tumor parameters after metastatic relapseE Planchat, X Durando, C Abrial, et al.
Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.
Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.
Breast (Edinburgh, Scotland)|August 20, 2011
Late lines of treatment benefit survival in metastatic breast cancer in current practice?E Planchat, C Abrial, E Thivat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution studyE Monrigal, J Dauplat, P Gimbergues, et al.
Annals of Surgical Oncology|March 4, 2008
Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentationP Gimbergues, C Abrial, X Durando, et al.
Pageof 6